Skip to main content

The FBI accuses China of trying to steal U.S. coronavirus vaccine research

The FBI and the Department of Homeland Security’s Cybersecurity and Infrastructure Security Agency have accused China of attempting to steal coronavirus vaccine research from the U.S.

“The FBI is investigating the targeting and compromise of U.S. organizations conducting COVID-19-related research by PRC-affiliated cyber actors and non-traditional collectors,” according to a joint announcement Wednesday.

Related Videos

“These actors have been observed attempting to identify and illicitly obtain valuable intellectual property (IP) and public health data related to vaccines, treatments, and testing from networks and personnel affiliated with COVID-19-related research,” the agencies said.

The FBI and CISA recommend that organizations conducting research increase their cybersecurity practices, including patching systems to close any critical vulnerabilities, scanning web applications for unauthorized access or modifications, and requiring multi-factor authentication.

The agency’s warning comes after a recent joint warning from the U.S. and the U.K. that groups “are actively targeting organizations involved in both national and international COVID-19 responses,” including “healthcare bodies, pharmaceutical companies, academia, medical research organizations, and local governments.”

The Trump administration has blamed China for being the source of the pandemic, including unproven claims by Secretary of State Mike Pompeo that the virus originated in a Wuhan lab.

He later walked back the claim after the Office of the Director of National Intelligence issued a statement saying it “concurs with the wide scientific consensus that the COVID-19 virus was not man-made or genetically modified.”

For the latest updates on the novel coronavirus outbreak, visit the World Health Organization’s COVID-19 page.

Editors' Recommendations

This vending machine gives out COVID tests, not candy bars
this vending machine gives out covid tests not candy bars test

From a distance, it looks like a regular candy bar dispenser, but get up close and you’ll quickly see that this is a vending machine with a difference.

For this one gives out not snacks but free COVID-19 tests.

Read more
AiroDoctor claims its four-stage air purifier can eliminate coronavirus
airodcotors four stage filter kills coronavirus airodoctor

As companies seek ways to introduce consumer-grade air purifiers that can kill the coronavirus, the main obstacle that has cropped up is the size of the virus itself. It is too small to be captured by most traditional filters, but AiroDoctor has introduced a commercially focused four-stage air purifier that uses a photocatalytic filter that it claims can destroy or neutralize viruses using UV LEDs.

The AiroDoctor uses a four-stage filter that can capture bacteria and viruses as small as 0.1 microns in size. It is capable of cleaning rooms up to 2,150 square feet with a single unit but runs at only 55 decibels. Because the AiroDoctor does not use UVC light, it doesn't produce ozone and requires no installation or HVAC integration in order to operate. This new technology means there are no dangerous byproducts from operating it, which is something that UVC filters have struggled to address.

Read more
Coronavirus vaccine researchers are being targeted by cyberattacks
Cambridge Biotech Moderna Leads in Race For Coronavirus Vaccine

Pharmaceutical companies and vaccine researchers working on a coronavirus vaccine have been the target of hacking attacks, a new report from Microsoft says. The company says these attacks are coming from nation-states, and it condemns the attacks and calls on other states to condemn them too.

Microsoft said in a blog post by Tom Burt, Corporate Vice President, Customer Security & Trust, that it has detected cyberattacks targeting both pharmaceutical companies and researchers in Canada, France, India, South Korea, and the U.S. Most of the attacks targeted organizations that were in the process of developing a coronavirus vaccine, especially those who were currently performing clinical trials.

Read more